115 related articles for article (PubMed ID: 16279790)
21. Synthesis and cytotoxic activity of MOM-ether analogs of isosteviol.
Malki A; Laha R; Bergmeier SC
Bioorg Med Chem Lett; 2014 Feb; 24(4):1184-7. PubMed ID: 24444475
[TBL] [Abstract][Full Text] [Related]
22. Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
Fukuda Y; Furuta H; Kusama Y; Ebisu H; Oomori Y; Terashima S
J Med Chem; 1999 Apr; 42(8):1448-58. PubMed ID: 10212131
[TBL] [Abstract][Full Text] [Related]
23. Anticancer double lipid prodrugs: liposomal preparation and characterization.
Arouri A; Mouritsen OG
J Liposome Res; 2011 Dec; 21(4):296-305. PubMed ID: 21438721
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and one-electron reduction characteristics of radiation-activated prodrugs possessing two 5-fluorodeoxyuridine units.
Tanabe K; Sugiura M; Ito T; Nishimoto S
Bioorg Med Chem; 2012 Sep; 20(17):5164-8. PubMed ID: 22847019
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid.
Linderoth L; Fristrup P; Hansen M; Melander F; Madsen R; Andresen TL; Peters GH
J Am Chem Soc; 2009 Sep; 131(34):12193-200. PubMed ID: 19663381
[TBL] [Abstract][Full Text] [Related]
26. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of quaternary amine ether lipids and evaluation of neoplastic cell growth inhibitory properties.
Morris-Natschke SL; Meyer KL; Marasco CJ; Piantadosi C; Rossi F; Godwin PL; Modest EJ
J Med Chem; 1990 Jun; 33(6):1812-8. PubMed ID: 2342075
[TBL] [Abstract][Full Text] [Related]
28. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
Pettit GR; Thornhill A; Melody N; Knight JC
J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of protoporphyrin-lipids and biological evaluation of micelles and liposomes.
Tachikawa S; El-Zaria ME; Inomata R; Sato S; Nakamura H
Bioorg Med Chem; 2014 Sep; 22(17):4745-51. PubMed ID: 25066052
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and use of novel ether phospholipid enantiomers to probe the molecular basis of the antitumor Effects of alkyllysophospholipids: correlation of differential activation of c-Jun NH(2)-terminal protein kinase with antiproliferative effects in neuronal tumor cells.
Samadder P; Bittman R; Byun HS; Arthur G
J Med Chem; 2004 May; 47(10):2710-3. PubMed ID: 15115414
[TBL] [Abstract][Full Text] [Related]
31. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Jain M; Fan J; Baturay NZ; Kwon CH
J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
[TBL] [Abstract][Full Text] [Related]
32. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells.
Dasari R; Banuls LM; Masi M; Pelly SC; Mathieu V; Green IR; van Otterlo WA; Evidente A; Kiss R; Kornienko A
Bioorg Med Chem Lett; 2014 Feb; 24(3):923-7. PubMed ID: 24393582
[TBL] [Abstract][Full Text] [Related]
33. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
34. Structure-based design, structure-activity relationship analysis, and antitumor activity of diaryl ether derivatives.
Yang SM; Huang ZN; Zhou ZS; Hou J; Zheng MY; Wang LJ; Jiang Y; Zhou XY; Chen QY; Li SH; Li FN
Arch Pharm Res; 2015 Oct; 38(10):1761-73. PubMed ID: 25724284
[TBL] [Abstract][Full Text] [Related]
35. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Yin H; Xu Y; Qian X; Li Y; Liu J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization and Akt phosphorylation inhibitory activity of cyclopentanecarboxylate-substituted alkylphosphocholines.
Alam MM; Joh EH; Park H; Kim B; Kim DH; Lee YS
Bioorg Med Chem; 2013 Apr; 21(7):2018-24. PubMed ID: 23415083
[TBL] [Abstract][Full Text] [Related]
38. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol-based cationic lipids for gene delivery: contribution of molecular structure factors to physico-chemical and biological properties.
Sheng R; Luo T; Li H; Sun J; Wang Z; Cao A
Colloids Surf B Biointerfaces; 2014 Apr; 116():32-40. PubMed ID: 24441456
[TBL] [Abstract][Full Text] [Related]
40. Development of new estradiol-cationic lipid hybrids: ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity.
Sudhakar G; Bathula SR; Banerjee R
Eur J Med Chem; 2014 Oct; 86():653-63. PubMed ID: 25222876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
